Nightingale Health’s mission is to build sustainable healthcare and reduce health inequalities. The company has developed the world’s most advanced health check for the health industry, providing risk detection for multiple chronic diseases from a single blood sample. Their Health Check can be scaled at low cost to entire populations, replacing many current risk assessments. This enables effective targeting and tracking of health interventions and better prevention of chronic diseases across populations. Nightingale operates globally from Finland with subsidiaries in Japan, the United States, Singapore, and the United Kingdom, serving customers in over 25 countries in healthcare and medical research. Their technology is used in leading health initiatives such as the UK Biobank and is validated by over 600 peer-reviewed publications.

From its founding in 2013 based on innovative blood test technology, the company has grown steadily. Notable milestones include regulatory approvals and CE marking in 2017; global expansion to Japan, the US, and Europe; the launch of consumer services; multiple strategic partnerships with health organizations; and listings on Nasdaq Helsinki and OTCQX International Market in 2025. Nightingale Health continues to innovate and expand its impact on preventative healthcare worldwide.

The company encourages talented and driven individuals to join their mission to transform healthcare from reactive sick care to preventative health. They employ professionals from diverse backgrounds such as sales, data science, chemistry, software development, and design. Nightingale promotes innovation, collaboration with global partners, and a compassionate work environment focused on making a meaningful difference in healthcare outcomes.